These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16791827)

  • 1. Cystic fibrosis enters the proteomics scene: new answers to old questions.
    Ollero M; Brouillard F; Edelman A
    Proteomics; 2006 Jul; 6(14):4084-99. PubMed ID: 16791827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Penque D
    Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of the "NADPH oxidases" (NOX/DUOX) family in cystic fibrosis.
    Pongnimitprasert N; El-Benna J; Foglietti MJ; Gougerot-Pocidalo MA; Bernard M; Braut-Boucher F
    Ann Biol Clin (Paris); 2008; 66(6):621-9. PubMed ID: 19091660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New concepts of pathophysiology and therapy in cystic fibrosis].
    Hirche TO; Loitsch S; Smaczny C; Wagner TO
    Pneumologie; 2005 Nov; 59(11):811-8. PubMed ID: 16385442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic and ionomic profiling reveals significant alterations of protein expression and calcium homeostasis in cystic fibrosis cells.
    Ciavardelli D; D'Orazio M; Pieroni L; Consalvo A; Rossi C; Sacchetta P; Di Ilio C; Battistoni A; Urbani A
    Mol Biosyst; 2013 Jun; 9(6):1117-26. PubMed ID: 23609890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics techniques for cystic fibrosis research.
    Roxo-Rosa M; Davezac N; Bensalem N; Majumder M; Heda GD; Simas A; Penque D; Amaral MD; Lukacs GL; Edelman A
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():85-9. PubMed ID: 15463934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein expression increases ATP release in respiratory cystic fibrosis cells.
    Naumann N; Siratska O; Gahr M; Rösen-Wolff A
    J Cyst Fibros; 2005 Sep; 4(3):157-68. PubMed ID: 15964250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative differential proteomics of cystic fibrosis cell models by SILAC (stable isotope labelling in cell culture).
    Guerrera IC; Ollero M; Vieu DL; Edelman A
    Methods Mol Biol; 2011; 742():213-25. PubMed ID: 21547735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR.
    Bhattacharyya S; Look D; Tobacman JK
    Clin Chim Acta; 2007 May; 380(1-2):122-7. PubMed ID: 17324393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new model of cystic fibrosis pathology: lack of transport of glutathione and its thiocyanate conjugates.
    Childers M; Eckel G; Himmel A; Caldwell J
    Med Hypotheses; 2007; 68(1):101-12. PubMed ID: 16934416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFTR in cystic fibrosis and cholera: from membrane transport to clinical practice.
    Goodman BE; Percy WH
    Adv Physiol Educ; 2005 Jun; 29(2):75-82. PubMed ID: 15905150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis.
    Ko JM; Kim GH; Kim KM; Hong SJ; Yoo HW
    J Korean Med Sci; 2008 Oct; 23(5):912-5. PubMed ID: 18955805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
    Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR
    Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
    Alibakhshi R; Zamani M
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathophysiologic mechanisms of cystic fibrosis lung disease.
    Soferman R
    Isr Med Assoc J; 2006 Jan; 8(1):44-8. PubMed ID: 16450752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B; Boeynaems JM
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misfolding of the cystic fibrosis transmembrane conductance regulator and disease.
    Cheung JC; Deber CM
    Biochemistry; 2008 Feb; 47(6):1465-73. PubMed ID: 18193900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.